Welcome to Tallinn – and welcome to Estonia!
On behalf of Ravimiamet, Estonian Agency for Medicines, we are pleased to invite you to the 15th International Conference of Drug Regulatory Authorities (ICDRA), which will be held in Tallinn, Estonia on 23-26 October 2012, preceded by Pre-Conference on 21-22 October 2012.
The Conference brings together the best expertise and knowledge from around the globe. We have an exciting list of plenaries and workshops that will provide information concerning important topics and current issues, and are planned to encourage discussion about the challenges for Drug Regulatory Authorities.
We would like to warmly recommend the events of the social programme - excursion on Wednesday afternoon, which offers the possibility to get to know some of the finest touristic spots in Tallinn and the Gala Dinner on Thursday offering Estonian folkloristic and culinary highlights.
The venue for the Conference will be Swissotel Tallinn, which should provide an ideal environment for the meeting, as well as being conveniently located to enjoy the historic city of our capital.
If you have any questions or need assistance during your stay in Tallinn, our colleagues from the ICDRA Organising Office will be happy to assist.
We hope that your visit will be a memorable one, allowing you to enjoy the interesting presentations and discussions, sharing the experience with colleagues from all over the world, holding fruitful discussions as well as using the possibilities to network as well as finding yourself located in the beautiful city of Tallinn.
Dr. Kristin Raudsepp
The Council of Europe’s European Directorate for the Quality of Medicines & HealthCare (EDQM) is pleased to have been invited to co-organise the 15th International Conference of Drug Regulatory Authorities (ICDRA) and the Pre-ICDRA Conference, which will take place in Tallinn, Estonia, in October 2012.
The ICDRA brings together representatives of regulatory authorities from all over the world. It is a forum for discussion and exchange of experience on all topics related to ensuring access to safe and efficacious medicines of good quality; these topics range from clinical trials to ensuring the security of the supply chain. The Pre-ICDRA conference, which will take place on the two days preceding the ICDRA, offers a unique opportunity for industry to participate in this discussion.
In 2012, the Pre-ICDRA will, amongst other topics, cover issues related to active pharmaceutical ingredients: how their quality can be assessed, what measures need to be taken to ensure they are manufactured in compliance with Good Manufacturing Practices and how to safely procure them, whilst making best use of work-sharing opportunities between authorities.
In an era of globalisation and ever scarcer resources, the collaboration of regulatory authorities is crucial for the protection of public health. Agreement on common standards and exchange of information are two important measures to be taken, and getting to know each other and networking between authorities is fundamental. However, to be successful in this undertaking, a frank discussion with stakeholders and notably the pharmaceutical industry is of greatest importance. Together with the Pre-ICDRA Conference, the ICDRA provides an excellent opportunity for this exchange.
We are very much looking forward to meeting you in Tallinn!
Dr. Susanne Keitel